Farewell Thunder Thighs, So Long Saddlebags: ZELTIQ(R) Aesthetics Launches Non-Surgical Solution to Significantly Reduce Fat ...
April 03 2014 - 2:00AM
Marketwired
Farewell Thunder Thighs, So Long Saddlebags: ZELTIQ(R) Aesthetics
Launches Non-Surgical Solution to Significantly Reduce Fat on Outer
Thighs
LONDON, UNITED KINGDOM--(Marketwired - Apr 3, 2014) - Visionary
medical device company ZELTIQ Aesthetics, Inc. (NASDAQ: ZLTQ), has
launched the CoolSmooth™ applicator, the first and only
non-surgical solution designed to reduce fat on the outer thighs,
with a comfortable design that adjusts to fit each unique
patient.
As the latest addition to the successful CoolSculpting® range of
applicators, CoolSmooth, when combined with CoolFit™ designed to
treat the inner thigh, now provides patients with the opportunity
to treat the entire thigh area.
A recent CoolSmooth clinical study of female patients who
received unilateral outer thigh treatments reflected high levels of
patient satisfaction:
- 86% of patients noticed visible fat reduction after just one
treatment
- 86% of patients were satisfied with their results
- 89% of patients would recommend the CoolSculpting procedure to
a friend1
"The introduction of the CoolSmooth applicator provides a new
solution to individuals who struggle to reduce fat in the thigh
area, a difficult-to-treat part of the body," said Mark Foley,
President and Chief Executive Officer of ZELTIQ. "Through our
newest applicator, we are excited by the opportunity to expand our
current offerings to physicians and, ultimately, the individuals
who may benefit from our unique technology. Results achieved with
CoolSmooth add to the growing body of evidence demonstrating the
safety, efficacy and long-lasting results of the CoolSculpting
procedure."
"The CoolSculpting system offers excellent results for patients
who find it difficult to eliminate fat on certain parts of their
bodies," said Dr. Natalie Blakely, Cosmetic Doctor and founder of
the Light Touch clinic. "The introduction of the CoolSmooth
applicator, now extends the areas available for treatment from the
CoolSculpting range, which include three particularly challenging
parts of the body -- the abdomen, flank and now thighs - and will
be welcomed by those who wish to improve the contour of their
bodies without invasive surgery."
A recent market research study revealed that 7.2 million people
expressed an interest in CoolSculpting as a solution for inner or
outer thigh fat1. This is in addition to the 13.2 million and
7.4 million interested in undergoing the CoolSculpting treatment
for the abdomen and flank1, respectively.
In the UK, the CoolSculpting treatment is approved for general
non-invasive fat reduction. Each CoolSculpting treatment
results in a noticeable reduction of fat in the treated areas, and
the treated fat cells are gone for good. Most patients can
start to see results as soon as three weeks following treatment,
with the most dramatic results occurring over a period of one to
three months. Every patient is unique, which is why ZELTIQ
recommends a customized treatment plan as part of the initial
consultation. Additional treatments in the same or multiple
areas may enhance the desired aesthetic effect.
Notes to
Editors
About the CoolSculpting® Procedure The CoolSculpting procedure
is a non-surgical, clinically proven procedure that selectively
reduces fat bulges in problem areas using a patented cooling
technology. The CoolSculpting procedure is U.S. FDA-cleared
and CE marked as a Class IIa medical device. It gently cools
unwanted fat cells in the body to induce a natural, controlled
elimination of fat cell without harming surrounding tissue, and the
treated fat cells are gone for good. Over 1,000,000
CoolSculpting cycles and 2,200 systems have been shipped to more
than 60 countries. The CoolSculpting procedure is available through
an elite network of CoolSculpting centers worldwide.
Dermatologists, plastic surgeons and leading aesthetic specialists
that offer CoolSculpting can be found at
www.coolsculpting.co.uk.
About ZELTIQ® Aesthetics, Inc. ZELTIQ Aesthetics, Inc. is a
medical technology company focused on developing and
commercializing products utilizing its proprietary
controlled-cooling technology platform. ZELTIQ's first
commercial product, the CoolSculpting system, is designed to
selectively reduce stubborn fat that may not respond to diet or
exercise. The CoolSculpting procedure is based on the
scientific principle that fat cells are more sensitive to cold than
the overlying skin and surrounding tissues. It utilizes
patented technology of precisely controlled cooling to reduce the
temperature of fat cells in the treated area, which is intended to
cause fat cell elimination through a natural biological process
known as apoptosis. ZELTIQ developed the CoolSculpting
procedure to safely, noticeably, and measurably reduce the fat
layer.
References: 1. Data on file. ZELTIQ Aesthetics, Inc.
Zeltiq Aesthetics, Inc. (NASDAQ:ZLTQ)
Historical Stock Chart
From Jun 2024 to Jul 2024
Zeltiq Aesthetics, Inc. (NASDAQ:ZLTQ)
Historical Stock Chart
From Jul 2023 to Jul 2024